Met Ö - Search Results

1

Arginase-2-specific cytotoxic T cells specifically recognize functional regulatory T cells.

Weis-Banke SE, Lisle TL, Perez-Penco M, Schina A, Hübbe ML, Siersbæk M, Holmström MO, Jørgensen MA, Marie Svane I, Met Ö, Ødum N, Madsen DH, Donia M, Grøntved L, Andersen MH. Weis-Banke SE, et al. Among authors: met o. J Immunother Cancer. 2022 Oct;10(10):e005326. doi: 10.1136/jitc-2022-005326. J Immunother Cancer. 2022. PMID: 36316062 Free PMC article.

2

Efficient large volume electroporation of dendritic cells through micrometer scale manipulation of flow in a disposable polymer chip.

Selmeczi D, Hansen TS, Met O, Svane IM, Larsen NB. Selmeczi D, et al. Among authors: met o. Biomed Microdevices. 2011 Apr;13(2):383-92. doi: 10.1007/s10544-010-9507-1. Biomed Microdevices. 2011. PMID: 21207149

3

[Chimeric antigen receptor T-cell therapy].

Müller K, Ifversen M, Kielsen K, Petersen SL, Met Ö, Svane IM. Müller K, et al. Among authors: met o. Ugeskr Laeger. 2019 Oct 14;181(20A):V05190309. Ugeskr Laeger. 2019. PMID: 31610841 Free article. Review. Danish.

4

In-chip fabrication of free-form 3D constructs for directed cell migration analysis.

Olsen MH, Hjortø GM, Hansen M, Met Ö, Svane IM, Larsen NB. Olsen MH, et al. Among authors: met o. Lab Chip. 2013 Dec 21;13(24):4800-9. doi: 10.1039/c3lc50930c. Lab Chip. 2013. PMID: 24153393

5

High immunogenic potential of p53 mRNA-transfected dendritic cells in patients with primary breast cancer.

Met O, Balslev E, Flyger H, Svane IM. Met O, et al. Breast Cancer Res Treat. 2011 Jan;125(2):395-406. doi: 10.1007/s10549-010-0844-9. Epub 2010 Mar 25. Breast Cancer Res Treat. 2011. PMID: 20336365

6

Cellular based cancer vaccines: type 1 polarization of dendritic cells.

Hansen M, Met Ö, Svane IM, Andersen MH. Hansen M, et al. Among authors: met o. Curr Med Chem. 2012;19(25):4239-46. doi: 10.2174/092986712802884213. Curr Med Chem. 2012. PMID: 22834814 Review.

7

Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients.

Ellebaek E, Iversen TZ, Junker N, Donia M, Engell-Noerregaard L, Met Ö, Hölmich LR, Andersen RS, Hadrup SR, Andersen MH, thor Straten P, Svane IM. Ellebaek E, et al. Among authors: met o. J Transl Med. 2012 Aug 21;10:169. doi: 10.1186/1479-5876-10-169. J Transl Med. 2012. PMID: 22909342 Free PMC article.

8

Comparison of clinical grade type 1 polarized and standard matured dendritic cells for cancer immunotherapy.

Hansen M, Hjortø GM, Donia M, Met Ö, Larsen NB, Andersen MH, thor Straten P, Svane IM. Hansen M, et al. Among authors: met o. Vaccine. 2013 Jan 11;31(4):639-46. doi: 10.1016/j.vaccine.2012.11.053. Epub 2012 Nov 29. Vaccine. 2013. PMID: 23200882

9

HLA-restricted CTL that are specific for the immune checkpoint ligand PD-L1 occur with high frequency in cancer patients.

Munir S, Andersen GH, Met Ö, Donia M, Frøsig TM, Larsen SK, Klausen TW, Svane IM, Andersen MH. Munir S, et al. Among authors: met o. Cancer Res. 2013 Mar 15;73(6):1764-76. doi: 10.1158/0008-5472.CAN-12-3507. Epub 2013 Jan 17. Cancer Res. 2013. PMID: 23328583

10

Simplified protocol for clinical-grade tumor-infiltrating lymphocyte manufacturing with use of the Wave bioreactor.

Donia M, Larsen SM, Met O, Svane IM. Donia M, et al. Among authors: met o. Cytotherapy. 2014 Aug;16(8):1117-20. doi: 10.1016/j.jcyt.2014.02.004. Epub 2014 May 13. Cytotherapy. 2014. PMID: 24831841

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters